OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
68 hedge funds and large institutions have $179M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 62 → 68 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
68
Holding in Top 10
1
Calls
$200K
Puts
$85K
Top Buyers
| 1 | +$7.51M | |
| 2 | +$3.97M | |
| 3 | +$3.21M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$1.89M |
| 5 |
QI
QS Investors
New York
|
+$1.23M |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$2.09M | |
| 3 | -$1.84M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.79M |
| 5 |
VAM
Visium Asset Management
New York
|
-$1.42M |